Product Liability Defense Favored By Industry Appears To Have Supreme Court Support

US FDA's rejection of Merck's proposed Fosamax label warning preempts state-law tort suits, several Justices appear to conclude, as Kagan and Sotomayor question whether the proposal focused on the right risk.

Facade of US Supreme court in Washington DC on sunny day

More from Drug Safety

More from Pink Sheet